Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $239,970 | 99 | 42.3% |
| Travel and Lodging | $166,973 | 138 | 29.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75,402 | 35 | 13.3% |
| Food and Beverage | $35,834 | 119 | 6.3% |
| Honoraria | $29,968 | 11 | 5.3% |
| Unspecified | $17,060 | 10 | 3.0% |
| Education | $2,003 | 2 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Health Care AG | $128,691 | 73 | $0 (2024) |
| Hexal AG | $104,157 | 56 | $0 (2020) |
| PFIZER INC. | $56,960 | 32 | $0 (2023) |
| Novo Nordisk AS | $53,359 | 26 | $0 (2024) |
| Novo Nordisk Inc | $53,281 | 59 | $0 (2023) |
| BioMarin Pharmaceutical Inc. | $47,744 | 61 | $0 (2024) |
| Ascendis Pharma Inc | $25,741 | 21 | $0 (2023) |
| TOLMAR Pharmaceuticals, Inc. | $20,111 | 16 | $0 (2022) |
| GENZYME CORPORATION | $18,769 | 18 | $0 (2020) |
| Tolmar, Inc. | $13,740 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50,831 | 43 | Novo Nordisk Health Care AG ($18,293) |
| 2023 | $159,234 | 115 | Novo Nordisk Health Care AG ($29,566) |
| 2022 | $57,415 | 35 | Novo Nordisk Health Care AG ($26,082) |
| 2021 | $41,710 | 26 | Novo Nordisk Health Care AG ($11,400) |
| 2020 | $31,292 | 26 | Hexal AG ($10,327) |
| 2019 | $62,547 | 66 | Novo Nordisk Health Care AG ($15,720) |
| 2018 | $84,112 | 58 | Hexal AG ($39,636) |
| 2017 | $80,068 | 45 | Hexal AG ($44,284) |
All Payment Transactions
414 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 11/27/2024 | Novo Nordisk AS | — | Travel and Lodging | In-kind items and services | $7,876.81 | General |
| 11/27/2024 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $6,300.00 | General |
| 11/27/2024 | Novo Nordisk AS | — | Travel and Lodging | In-kind items and services | $367.58 | General |
| 11/27/2024 | Novo Nordisk AS | — | Travel and Lodging | In-kind items and services | $299.87 | General |
| 11/27/2024 | Novo Nordisk AS | — | Food and Beverage | In-kind items and services | $220.56 | General |
| 11/27/2024 | Novo Nordisk AS | — | Travel and Lodging | In-kind items and services | $34.84 | General |
| 11/27/2024 | Novo Nordisk AS | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15.00 | General |
| 11/19/2024 | Novo Nordisk Health Care AG | — | Consulting Fee | Cash or cash equivalent | $4,300.00 | General |
| 11/19/2024 | Novo Nordisk Health Care AG | — | Travel and Lodging | In-kind items and services | $551.98 | General |
| 11/19/2024 | Novo Nordisk Health Care AG | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 11/19/2024 | Novo Nordisk Health Care AG | — | Food and Beverage | In-kind items and services | $253.98 | General |
| 11/19/2024 | Novo Nordisk Health Care AG | — | Travel and Lodging | In-kind items and services | $169.54 | General |
| 11/18/2024 | Tolmar, Inc. | FENSOLVI (Drug) | Food and Beverage | Cash or cash equivalent | $29.28 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/16/2024 | Novo Nordisk Health Care AG | Sogroya (Biological) | Consulting Fee | Cash or cash equivalent | $5,100.00 | General |
| Category: Growth Hormone | ||||||
| 11/16/2024 | Novo Nordisk Health Care AG | Sogroya (Biological) | Travel and Lodging | In-kind items and services | $4,430.27 | General |
| Category: Growth Hormone | ||||||
| 11/16/2024 | Novo Nordisk Health Care AG | Sogroya (Biological) | Travel and Lodging | In-kind items and services | $1,310.46 | General |
| Category: Growth Hormone | ||||||
| 11/16/2024 | Novo Nordisk Health Care AG | Sogroya (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $681.29 | General |
| Category: Growth Hormone | ||||||
| 11/16/2024 | Novo Nordisk Health Care AG | Sogroya (Biological) | Travel and Lodging | In-kind items and services | $255.92 | General |
| Category: Growth Hormone | ||||||
| 11/16/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Food and Beverage | In-kind items and services | $74.14 | General |
| Category: Achondroplasia | ||||||
| 09/24/2024 | Amgen Inc. | PROCYSBI (Biological) | Consulting Fee | Cash or cash equivalent | $1,740.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/02/2024 | Novo Nordisk Health Care AG | Sogroya (Biological) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Growth Hormone | ||||||
| 05/31/2024 | Novo Nordisk Health Care AG | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 05/02/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Food and Beverage | In-kind items and services | $227.79 | General |
| Category: Achondroplasia | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MOD4023 OPKO CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $8,610 | 5 |
| SOMATROGON CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $5,250 | 4 |
| NGENLA CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $3,200 | 1 |
About Dr. Bradley Miller, M.D
Dr. Bradley Miller, M.D is a Pediatrics healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184633059.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Miller, M.D has received a total of $567,210 in payments from pharmaceutical and medical device companies, with $50,831 received in 2024. These payments were reported across 414 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($239,970).
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Endocrinology
- Location Minneapolis, MN
- Active Since 08/07/2006
- Last Updated 04/23/2015
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1184633059
Products in Payments
- Omnitrope (Drug) $104,157
- Norditropin (Drug) $67,549
- Norditropin (Biological) $61,840
- GENOTROPIN (Drug) $33,309
- Sogroya (Biological) $30,878
- FENSOLVI (Drug) $26,992
- SKYTROFA (Drug) $13,716
- NO PRODUCT DISCUSSED (Drug) $8,967
- TZIELD (Biological) $8,593
- PROCYSBI (Biological) $7,957
- VOXZOGO 1.2mg (Biological) $7,421
- ELIGARD (Drug) $6,859
- VOXZOGO 1.2mg (Drug) $5,819
- Diazoxide Choline Controlled Release (DCCR) (Drug) $5,435
- Thyquidity (Drug) $4,000
- ALDURAZYME (Drug) $3,377
- NGENLA (Drug) $2,789
- SUPPRELIN (Drug) $2,405
- OMNITROPE (Drug) $2,319
- INCRELEX (Drug) $2,000
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Minneapolis
Dr. Bruce Blazar, M.d, M.D
Pediatrics — Payments: $1.1M
Kyriakie Sarafoglou, Md, MD
Pediatrics — Payments: $368,453
Dr. Sheldon Mauer, Md, MD
Pediatrics — Payments: $175,979
Heather Stefanski, Md, Ph.d, MD, PH.D
Pediatrics — Payments: $159,475
Antoinette Moran, M.d, M.D
Pediatrics — Payments: $98,422
Kiran Belani, Mbbs Md, MBBS MD
Pediatrics — Payments: $66,261